D.A. Vorobiof
Impact in
-
- Ovarian cancer diagnosis and treatment
-
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 2
- Cancer Treatment and Pharmacology 1
- Cancer Diagnosis and Treatment 1
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Economic and Financial Impacts of Cancer 2
- Health Systems, Economic Evaluations, Quality of Life 1
- Co-authors
- Bernardo L. Rapoport (3 shared papers)Mitch Dowsett (1 shared paper)David Dodwell (1 shared paper)Ulrich R. Kleeberg (1 shared paper)J.F.R. Robertson (1 shared paper)Martin Chasen (1 shared paper)Adina Alberts (1 shared paper)Johann Raats (1 shared paper)
- Journals
- Annals of Oncology (3 papers)European Journal of Cancer (1 paper)International Journal of Gynecological Cancer (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- United KingdomIsraelSouth Africa
In The Last Decade
D.A. Vorobiof
6 papers receiving 10 citations
Peers
Comparison fields: 5 of 12
- Reproductive Medicine 3
- Cancer Research 5
- Oncology 7
- Obstetrics and Gynecology 2
- Genetics 4
Countries citing papers authored by D.A. Vorobiof
This map shows the geographic impact of D.A. Vorobiof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Vorobiof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Vorobiof more than expected).
Fields of papers citing papers by D.A. Vorobiof
This network shows the impact of papers produced by D.A. Vorobiof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Vorobiof. The network helps show where D.A. Vorobiof may publish in the future.
Co-authors
The 15 scholars most cited alongside D.A. Vorobiof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 4 | |
| 2 | 2003 | 2 | |
| 3 | 2019 | 2 | |
| 4 | 2020 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2003 | 1 |
About D.A. Vorobiof
D.A. Vorobiof is a scholar working on Oncology, Economics and Econometrics, Reproductive Medicine, Molecular Biology and Genetics, having authored 6 papers that have together received 11 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (2 papers), Economic and Financial Impacts of Cancer (2 papers), Cancer Treatment and Pharmacology (1 paper), Cancer Diagnosis and Treatment (1 paper), Estrogen and related hormone effects (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Cancer therapeutics and mechanisms (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Reproductive Medicine (3 citations), Cancer Research (5 citations), Oncology (7 citations), Obstetrics and Gynecology (2 citations) and Genetics (4 citations). D.A. Vorobiof has collaborated with scholars based in United Kingdom, Israel and South Africa. Frequent co-authors include Bernardo L. Rapoport, Mitch Dowsett, David Dodwell, Ulrich R. Kleeberg, J.F.R. Robertson, Martin Chasen, Adina Alberts, Johann Raats, Einav Sapir and Andrey Litvin. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, International Journal of Gynecological Cancer and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.